Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

Topics

Ozempic and Wegovy officially moved off FDA's drug shortage list

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration's (FDA) drug shortage list nearly ...
The Hill - 10h
FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.
MarketWatch - 13h
FDA declares end to Wegovy and Ozempic shortage

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
CBS News - 15h
The Ozempic Shortage Is Over—for Now

The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs.
Inc. - 15h
The Ozempic Shortage Is Over

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.
Wired - 15h
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
CNBC - 10h
Veterinarian and 13 Horse Trainers Violated Drug Rules, U.S. Regulator Says

Thirty percent of the horses never raced again and seven died, the Horseracing Integrity and Safety Authority said.
The New York Times - 8h
FDA’s Food Safety Chief Resigns

The chief said the loss of critical employees overseeing the nation’s food supply made his work impossible. Robert F. Kennedy Jr., the nation’s new health secretary, has pledged to gut the division.
The New York Times - 3d
Ozempic: $1,400/Month—Compounded Version: $250/Month

The real cost? Your medical license.
Inc. - 2d

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

Topics

Related

Ozempic and Wegovy officially moved off FDA's drug shortage list

FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

FDA declares end to Wegovy and Ozempic shortage

The Ozempic Shortage Is Over—for Now

The Ozempic Shortage Is Over

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

Veterinarian and 13 Horse Trainers Violated Drug Rules, U.S. Regulator Says

FDA’s Food Safety Chief Resigns

Ozempic: $1,400/Month—Compounded Version: $250/Month

More from CNBC

Steve Cohen says tariffs and DOGE's cuts are negative for economy, market correction could be soon

Battered and bruised after 3 years of war, Ukraine is up against the ropes as U.S. backing vanishes

UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months

President Trump is losing the stock market war to the rest of the world so far. Here's where investors are taking advantage

Elon Musk has a problem with X's Community Notes when he disapproves of the results

More in Business

Battered and bruised after 3 years of war, Ukraine is up against the ropes as U.S. backing vanishes

The anti-woke overcorrection is here

My husband and I have been married for 18 years. We share a son — and my husband has a daughter. Why should they get an equal inheritance?

‘She’s bleeding her retirement dry’: My friend earns $9 an hour, but wastes money on vacations and massages. What can I do?

‘I feel like I’ve opened a hornet’s nest’: My mother-in-law lists my husband as beneficiary on her $1 million IRA. But her will says otherwise. Who wins?